Search

Your search keyword '"Ding, P"' showing total 2,290 results

Search Constraints

Start Over You searched for: Author "Ding, P" Remove constraint Author: "Ding, P" Topic neoplasms. tumors. oncology. including cancer and carcinogens Remove constraint Topic: neoplasms. tumors. oncology. including cancer and carcinogens
2,290 results on '"Ding, P"'

Search Results

1. Risk assessment and triage strategy of cervical cancer primary screening on HPV integration status: 5-year follow-up of a prospective cohort study

2. Neutralizing antibodies elicited in macaques recognize V3 residues on altered conformations of HIV-1 Env trimer

3. Negative association of C-reactive protein-albumin-lymphocyte index (CALLY index) with all-cause and cause-specific mortality in patients with cancer: results from NHANES 1999–2018

4. Cell-permeated peptide P-T3H2 inhibits malignancy on hepatocellular carcinoma through stabilizing HNF4α protein

5. Identification of common core genes and pathways in childhood sepsis and cancer by bioinformatics analysis

6. PD-1/PD-L1 immune checkpoint blockade in breast cancer: research insights and sensitization strategies

7. ILF2 protein is a promising serum biomarker for early detection of gastric cancer

8. The first-in-class bispecific antibody IBI318 (LY3434172) targeting PD-1 and PD-L1 in patients with advanced tumors: a phase Ia/Ib study

9. Predicting survival in bladder cancer with a novel apoptotic gene-related prognostic model

10. Exploring new mechanisms in cancer molecular pathways and pathogenic cell transformation: PIP4K2A as a prognostic marker and therapeutic target in cutaneous malignant melanoma

11. Nomogram for predicting cervical lymph node metastasis of papillary thyroid carcinoma using deep learning-based super-resolution ultrasound image

12. Transcriptional and post-transcriptional regulation of CARMN and its anti-tumor function in cervical cancer through autophagic flux blockade and MAPK cascade inhibition

13. Circ_0001741 exerts as a tumor promoter in ovarian cancer through the regulation of miR-491-5p/PRSS8 axis

14. The potential of kaempferol in digestive system tumors: recent advances and mechanistic insights

15. Multi-omics analysis of Prolyl 3-hydroxylase 1 as a prognostic biomarker for immune infiltration in ccRCC

16. CRISPR/Cas9 screens identify key host factors that enhance rotavirus reverse genetics efficacy and vaccine production

17. A Comparison of Stereotactic Radiation Therapy in Elderly Patients with Central or Peripheral Stage I-II (T1-3 N0 M0) Non-Small Cell Lung Cancer

18. Unveiling the significance of cancer-testis antigens and their implications for immunotherapy in glioma

19. Tucidinostat plus pediatric-inspired chemotherapy for newly diagnosed adult ETP-ALL/LBL: a single-arm, phase 2 trial

20. A comprehensive investigation of Glycoprotein-based nucleic acid vaccines for Hantaan Virus

21. Can we skip invasive biopsy of sentinel lymph nodes? A preliminary investigation to predict sentinel lymph node status using PET/CT-based radiomics

22. A-to-I-edited miR-1251-5p restrains tumor growth and metastasis in lung adenocarcinoma through regulating TCF7-mediated Wnt signaling pathway

23. Non-invasive miRNAs for early detection and diagnosis of lacrimal adenoid cystic carcinoma

24. Integrated immunogenomic analyses of single-cell and bulk profiling construct a T cell-related signature for predicting prognosis and treatment response in osteosarcoma

25. Cross-institutional evaluation of deep learning and radiomics models in predicting microvascular invasion in hepatocellular carcinoma: validity, robustness, and ultrasound modality efficacy comparison

26. Differentiation of pathological subtypes and Ki-67 and TTF-1 expression by dual-energy CT (DECT) volumetric quantitative analysis in non-small cell lung cancer

27. Effect of genistein supplementation on microenvironment regulation of breast tumors in obese mice

28. Continuation of same programmed death-1 inhibitor regime beyond progression is a novel option for advanced gastric cancer

29. Reconstruction of cancer marker analysis with holistic anatomical precision implicates heterogeneity development during breast tumor progression

30. Circ_0001047 inhibits prostate cancer progression and enhances abiraterone sensitivity via miR-122-5p/FKBP5/PHLPP1/AKT axis in vitro

32. Proteomics and Phosphoproteomics Analysis of Effect of Retinoic Acid-Induced Protein 16 Knockout on Human Colon Cancer Cells

33. Sequential Autologous CIK/NK Cells Combined with Chemotherapy to Induce Long-Term Tumor Control in Advanced Rectal Cancer: A Case Report

34. Amodiaquine ameliorates stress-induced premature cellular senescence via promoting SIRT1-mediated HR repair

35. Proapoptotic activity of JNK-sensitive BH3-only proteins underpins ovarian cancer response to replication checkpoint inhibitors

36. Node-sparing modified short-course Radiotherapy Combined with CAPOX and Tislelizumab for locally Advanced MSS of Middle and low rectal Cancer (mRCAT): an open-label, single-arm, prospective, multicentre clinical trial

37. FTO/m6A mediates miR-138-5p maturation and regulates gefitinib resistance of lung adenocarcinoma cells by miR-138-5p/LCN2 axis

38. Thulium laser en bloc resection reduces recurrence rates in NMIBC patients with tumor diameters ≥3cm compared to transurethral resection: a non-randomized controlled study

39. Prognostic factors and prognostic model of non-metastatic clear cell renal cell carcinoma

40. Effects of dietary habits and catheterization type on breast cancer-related lymphedema: a retrospective cohort study

41. Prognostic risk model of LIHC T-cells based on scRNA-seq and RNA-seq and the regulation of the tumor immune microenvironment

42. Immune‐inflammatory markers and clinical characteristics as predictors of the depth of response and prognosis of patients with PD‐L1 ≥50% metastatic non‐small cell lung cancer receiving first‐line immunotherapy

43. Application of 3D bioprinting in cancer research and tissue engineering

44. Targeting N4‐acetylcytidine suppresses hepatocellular carcinoma progression by repressing eEF2‐mediated HMGB2 mRNA translation

45. Sulindac (K-80003) with nab-paclitaxel and gemcitabine overcomes drug-resistant pancreatic cancer

46. Neuroblastoma with high ASPM reveals pronounced heterogeneity and poor prognosis

47. Is clinical target volume necessary for locally advanced non-small cell lung cancer treated with 4D-CT intensity-modulated radiation therapy

48. A urine-based liquid biopsy for detection of upper tract urothelial carcinoma: a self-matched study

49. Regulator of nonsense transcripts 3B is a prognostic biomarker and associated with immune cell infiltration in lung squamous cell and hepatocellular carcinoma

50. Actin like 6A is a prognostic biomarker and associated with immune cell infiltration in cancers

Catalog

Books, media, physical & digital resources